77.785M
About BIOASIS TECHNOLOGIES INC
Sector
Industry
CEO
Deborah A. Rathjen
Website
Headquarters
New Haven
Founded
2006
ISIN
CA09064N1033
biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
